|
SLC25A15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05424566246393E-12 |
| Normal-vs-Stage2 |
5.90299997771382E-09 |
| Normal-vs-Stage3 |
3.08890002465034E-09 |
| Normal-vs-Stage4 |
2.26409999999344E-05 |
| Stage1-vs-Stage2 |
9.268800E-01 |
| Stage1-vs-Stage3 |
9.534000E-01 |
| Stage1-vs-Stage4 |
8.057000E-01 |
| Stage2-vs-Stage3 |
9.891000E-01 |
| Stage2-vs-Stage4 |
7.144400E-01 |
| Stage3-vs-Stage4 |
7.622400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62536650805123E-12 |
| Normal-vs-AfricanAmerican |
4.05753208809756E-12 |
| Normal-vs-Asian |
2.07249999999437E-05 |
| Caucasian-vs-AfricanAmerican |
7.856400E-01 |
| Caucasian-vs-Asian |
3.843200E-01 |
| AfricanAmerican-vs-Asian |
2.933400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.87449961003483E-10 |
| Male-vs-Female |
1.107690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.40719999991634E-07 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
4.66293670342566E-15 |
| Normal-vs-Extreme_Obese |
1.771030E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.718400E-02 |
| Normal_Weight-vs-Obese |
3.245400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.400600E-01 |
| Extreme_Weight-vs-Obese |
2.588400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.524360E-01 |
| Obese-vs-Extreme_Obese |
3.304200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.29480048483811E-10 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-15 |
| Normal-vs-Age(61-80Yrs) |
2.14606110660043E-13 |
| Normal-vs-Age(81-100Yrs) |
2.77260003844759E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.600800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.269800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.827600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.944000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.904000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.973600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.02688993261791E-12 |
| Normal-VS-Type2 PRCC |
1.23119999972943E-07 |
| Normal-VS-KIRP CIMP |
1.42800000002552E-06 |
| Normal-VS-Unclassified PRCC |
1.11559994575572E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.570400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.601600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.792400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.706240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.383400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.181400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
6.10209999973854E-07 |
| Normal-vs-N2 |
1.156380E-04 |
| N0-vs-N1 |
3.883500E-02 |
| N0-vs-N2 |
3.596000E-01 |
| N1-vs-N2 |
1.399970E-01 |
|
|
